Systemic medications that target glycemic control and coexisting conditions in diabetes mellitus can have beneficial or deleterious effects on the onset or progression of diabetic retinopathy. This article reviews current knowledge of the ocular-specific effects of systemic medications commonly used by patients with diabetes mellitus, including those directed at control of hyperglycemia, dyslipidemia, hypertension, cardiac disease, anemia, inflammation and cancer.
- Paolo S. Silva
- Jerry D. Cavallerano
- Lloyd Paul Aiello
